Effect of wild mint on oligomenorrhea
Phase 3
- Conditions
- Oligomenorrhea.Secondary oligomenorrhoea
- Registration Number
- IRCT201110027690N1
- Lead Sponsor
- Shahed University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Patient satisfaction; Outpatients aged between18-35 years; More than two months of oligomenorrhea; Negative pregnancy test; Not breastfeeding; Patient's hormones (TSH, FSH, PRL) not higher than normal; No Hormonal treatment (chemical or plant) is allowed at the same time; No malignancies; No chronic kidney disease and liver disease; Stress is not one of the reason for delayed menstruation. Exclusion criteria: Patients that use hormone therapy; Patients who experienced side effects; Patients who need surgery and other interventions; Patients with a personal decision to exit from the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Start of bleeding. Timepoint: Before intervention and 1, 2 & 3 months later. Method of measurement: Question.;FSH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;LH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Free testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: During the study. Method of measurement: Question.